Thomas P. Cappola, MD, ScM
Cardiology
Headshot of Thomas P. Cappola, MD, ScM

Thomas P. Cappola, MD, ScM

Cardiology
Sees patients age 18 and up
Penn Heart and Vascular Center
Headshot of Thomas P. Cappola, MD, ScM
Penn Medicine Provider

About me

  • Chief, Division of Cardiovascular Medicine
  • William Smilow Professor

My education and training

  • Harvard UniversityMedical School
  • Massachusetts General Hospital/Brigham and Women’s HospitalResidency
  • Johns Hopkins HospitalFellowship

Spoken languages

English
English

Reviews

Average Rating

46 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
October 2026
Explains issues in terms I can understand. Very patient & takes appropriate amount of time for appt.
Anonymous
April 2026
dr cappola is the best!
Anonymous
September 2025
dr cappola is simply the best
Anonymous
September 2025
excellent, dr

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Cappola is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Kim M, Subramanian V, Tavolinejad H, Sarmiento Bustamante M, Pourmussa B, Mann DL, Javaheri A, Richards AM, Doughty RN, Rietzschel E, van Empel V, Zamani P, Cappola TP, Tong D, Chung S, Pandey A, Chirinos JA. Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction. , Circ Heart Fail: 2026,e014345


Sunderland N, Asselin G, Henry A, Nelson CP, Lemieux Perreault LP, Asselbergs FW, Boersma E, Cappola TP, Chazara O, Chutkow W, Cyr MC, Gkatzionis A, Gui H, Haefliger C, Hedman ÅK, Hillege H, Hyde CL, Kamanu FK, Kardys I, Koekemoer AL, Kraus WE, Lang CC, Malarstig A, Margulies KB, Marston NA, Melloni GEM, Morley MP, O'Donoghue ML, Owens AT, Paul DS, Tilling K, van der Harst P, van Setten J, van Vugt M, Verweij N, Veluchamy A, Wallentin L, Wang X, Xing H, Yang Y, White HD, Zannad F, Smith JG, Brunner-La Rocca HP, Lanfear DE, Mann DL, de Denus S, Tardif JC, Voors AA, Samani NJ, Ellinor PT, Ruff CT, Sabatine MS, Sattar N, McMurray JJV, Paternoster L, Dubé MP, Lumbers RT. Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study. , J Am Coll Cardiol., 87(21): 2026,2981-2992


Zelleke AB, Azzo JD, Moreno JD, Mann DL, Cappola TP, Chirinos JA, Javaheri A. RACGAP1 as a Circulating Biomarker of Atrial Fibrillation in Heart Failure: A Dual-Cohort Proteomic Study , Circ Arrhythm Electrophysiol, 19(5): 2026,e014024


Skarke C, El Jamal N, Genuardi MV, Brooks TG, Mrčela A, Lahens NF, Cordoza M, Sarles S, Mbadugha A, Karunamuni DR, Gupta S, Bae CJ, Sehgal A, Cappola TP, Gutsche JT, Atluri P, Desai ND, Acker MA, Grant GR, Schwab RJ, Rosen IM, FitzGerald GA. Quantifying sleep wake rhythms in the hospital environment with digital technologies , NPJ Digit Med, 9(1): 2026,479


Abramowitz SA, Hoffman-Andrews L, Zhang D, Judy R, Cappola TP, Day SM, Reza N, Owens AT, Damrauer SM, Levin MG; Penn Medicine BioBank. Polygenic Background and Penetrance of Pathogenic Variants in Hypertrophic and Dilated Cardiomyopathies. , JAMA Cardiol, 11(2): 2026,147-155


Vidula MK, Schurgers LJ, Zhao L, Dib MJ, Zhao M, Wang Z, Ebert C, Salman O, Azzo JD, Zamani P, van Empel V, Richards AM, Doughty R, Javaheri A, Mann DL, Rietzschell E, Kammerhoff K, Schafer P, Seiffert DA, Ramirez-Valle F, Cappola TP, Chirinos JA. Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure. , Circ Heart Fail, 19(2): 2026,e012734


Mann DL, Chirinos JA, Yu J, Yang W, McNamara DM, Richards B, Taddei-Peters WC, Jeffries N, Stewart GC, Qian C, Cappola TP, Aaronson KD; REVIVAL Investigators. Circulating Proteomic Profiles in Ambulatory Patients With Advanced Stage C2D Heart Failure: Insights From the Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL) Registry. , J Card Fail, 32(8): 2026,1451-1455


Vajargah KK, Dib MJ, Tavolinejad H, Zamani P, Richards AM, Mann DL, Rietzschel E, van Empel V, Burgess S, Cappola TP, Chirinos JA. Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction. , JACC Heart Fail: 2025,102771


Woerner J, Westbrook TM, Joo J, Shivakumar M, Venkatesh R, Cherlin T, Jung SH, Jeong S, Maseda D, McKeague M, Shwetank, Ionita M, Wagenaar J, Abramowitz SA, Verma A, Zhao B, Lee S, Damrauer S, Levin MG, Heo SC, Cappola TP, Rader DJ, Day S, Deo R, Gelfand JM, Ramessur R, Guerraty MA, Setia-Verma S, Pasaniuc B, Ritchie MD, Apostolidis SA, Greenplate AR, Wherry EJ; Penn Medicine Biobank; Nam Y, Kim D. Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction. , medRxiv [Preprint]: 2025,25331242


Lindholm ME, Abramowitz S, Waggott DM, Grove ME, Dewey FE, Pan C, Pavlovic A, Shang C, Huang Y, Bensabath L, Goldfeder RL, Cordero P, Erbilgin A, Priest JR, Chaib H, Puckelwartz MJ, Day SM, McNally EM, Cappola T, Dorn GW, Ashley EA, Wheeler MT Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling , Front Cardiovasc Med, 12: 2025,1546493


View all publications